Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1alpha, 25-dihydroxy-22-oxacalcitriol) in 17 patients.
Imagawa
Ichiro
I
Suzuki
Hiroyuki
H
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy*
D003879:Dermatologic Agents; D002117:Calcitriol; C051883:maxacalcitol